Last updated: Nov 20, 2026, 12:00 AM

Inhibikase Therapeutics Inc Exchange (NASDAQ, USD)

IKT

1.38
-0.07 (-4.83%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-9.80%
3 year return (CAGR)
11.33%
5 year return (CAGR)
-35.68%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
192.56M
Price/Sales
-
Ent value
171.61M
Price/Book
1.26
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-25.09%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open1.45
Daily high1.49
Daily low1.37
Daily Volume670K
All-time high58.80
1y analyst estimate5.55
Beta0.94
EPS (TTM)-0.35
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Inhibikase Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
IKTS&P500
Current price drop from All-time high-97.65%-5.99%
Highest price drop-98.62%-56.47%
Date of highest drop9 Oct 20239 Mar 2009
Avg drop from high-88.82%-10.64%
Avg time to new high741 days12 days
Max time to new high1481 days1805 days